JAK2 V617F, hemostatic polymorphisms, and clinical features as risk factors for arterial thrombotic events in essential thrombocythemia

Ann Hematol. 2008 Sep;87(9):763-5. doi: 10.1007/s00277-008-0474-z. Epub 2008 Mar 26.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Amino Acid Substitution*
  • Female
  • Humans
  • Janus Kinase 2 / genetics*
  • Male
  • Middle Aged
  • Polymorphism, Genetic*
  • Risk Factors
  • Thrombocythemia, Essential / genetics*
  • Thrombosis / complications
  • Thrombosis / genetics*

Substances

  • JAK2 protein, human
  • Janus Kinase 2